Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial
At week 52 of the PaTHway trial, TransCon PTH showed sustained efficacy, safety, and tolerability in adults with hypoparathyroidism.
Authors
- Lorenz Christian Hofbauer (ORCID: https://orcid.org/0000-0002-8691-8423)
- Xuebei An
- Bryant Lai
- Dolores Shoback (ORCID: https://orcid.org/0000-0003-2936-4468)
- Christopher T. Sibley (ORCID: https://orcid.org/0009-0002-7534-7175)
- Lisa G Abbott
- Susanne Pihl
- B.L. Clarke (ORCID: https://orcid.org/0000-0002-3801-9546)
- Jenny Ukena
- Aimee D Shu (ORCID: https://orcid.org/0000-0003-1801-5289)
- Peter Schwarz (ORCID: https://orcid.org/0000-0002-0483-8594)
- Filomena Cetani (ORCID: https://orcid.org/0000-0003-2558-9547)
- Aliya Khan (ORCID: https://orcid.org/0000-0003-3733-8956)
- Lars Rejnmark (ORCID: https://orcid.org/0000-0002-2152-4247)
- Andrea Palermo
- Alden Smith (ORCID: https://orcid.org/0000-0003-1582-534X)
- Tamara Vokes (ORCID: https://orcid.org/0000-0003-1628-9673)
- Mishaela R. Rubin
- Lynn Kohlmeier
- Claudia Gagnon (ORCID: https://orcid.org/0000-0001-9623-962X)
Institutions
- San Francisco VA Medical Center (US)
- University of Nevada, Reno (US)
- Università Campus Bio-Medico (IT)
- University of California, San Francisco (US)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- University of Chicago (US)
- Health Outcomes Solutions (United States) (US)
- Ascendis Pharma (Denmark) (DK)
- Mayo Clinic in Arizona (US)
- Campus Bio Medico University Hospital (IT)
- Arthritis Northwest (US)
- Azienda Ospedaliera Universitaria Pisana (IT)
- Université Laval (CA)
- Columbia University (US)
- Technische Universität Dresden (DE)
- McMaster University (CA)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1210/clinem/dgae693
- Citations
- 24
- Primary Topic
- Thyroid and Parathyroid Surgery
- Type
- article
- Field-Weighted Citation Impact
- 13.75